Biogen Pharmachem Industries Ltd
03 Nov 2026 12:00 AM
Biogen Pharmachem Industries reported no unutilized funds from past offerings to the BSE,
Biogen Pharmachem Industries Limited, formerly Sun Techno Overseas Limited, informed the BSE on November 3, 2026, that it has no unutilized funds remaining from any past public issue, rights issue, preferential issue, or qualified institutional placement as of September 30, 2026, and therefore is not providing information via Annexure-A as required by SEBI regulations.
Biogen Pharmachem Industries Ltd
06 Oct 2026 12:00 AM
Biogen Pharmachem Industries confirmed regulatory compliance for the quarter ended September 30, 2026,
Biogen Pharmachem Industries Limited, formerly Sun Techno Overseas Limited, submitted a certificate to the BSE Limited on October 6, 2026, confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, with Satellite Corporate Services Private Limited acting as the Registrar & Share Transfer Agent; the certificate noted no physical certificates were received for dematerialization of securities during the quarter.
Biogen Pharmachem Industries Ltd
17 Sep 2026 12:00 AM
Biogen Pharmachem closes securities trading window ahead of Q2 earnings announcement,
Biogen Pharmachem Industries Limited informed the BSE that the trading window for dealing in the company`s securities will be closed from October 1, 2026, until 48 hours after the announcement of the unaudited financial results for the second quarter ended September 30, 2026, in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
Biogen Pharmachem Industries Ltd
04 Sep 2026 12:00 AM
Biogen Pharmachem Industries closes share transfer books September 22-29 for AGM voting,
Biogen Pharmachem Industries Limited informed the BSE that the register of members and share transfer books will remain closed from September 22, 2026, to September 29, 2026, for the Annual General Meeting, with electronic voting commencing on September 26, 2026, at 09:00 A.M. and concluding on September 28, 2026, at 05:00 P.M., with a cut-off date of September 22, 2026, to determine voting eligibility.
Biogen Pharmachem Industries Ltd
05 Aug 2026 12:00 AM
Biogen Pharmachem Industries standalone net profit declines 83.58% in the June 2026 quarter,
Net profit of Biogen Pharmachem Industries declined 83.58% to Rs 0.22 crore in the quarter ended June 2026 as against Rs 1.34 crore during the previous quarter ended June 2025. There were no Sales reported in the quarter ended June 2026 and during the previous quarter ended June 2025.Powered by Capital Market - Live News
Subscribe for our
newsletter
newsletter
HSL Mobile App